TNFα accelerates monocyte to endothelial transdifferentiation in tumors by the induction of integrin α5 expression and adhesion to fibronectin

Molecular Cancer Research

Volumn 9, Issue 6, 2011, Pages 702-711

  Li, Bin ^a   Pozzi, Ambra ^b,c   Young, Pampee P ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; VERY LATE ACTIVATION ANTIGEN 5; CADHERIN; LEUKOCYTE ANTIGEN;

ADHESION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; MONOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ANIMALS; ANTIGENS, CD; CADHERINS; CELL ADHESION; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; ENDOTHELIUM; FIBRONECTINS; GENE EXPRESSION PROFILING; HUMANS; INTEGRIN ALPHA5BETA1; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C57BL; MONOCYTES; MYELOID CELLS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 79959236991     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0484     Document Type: Article

References (39)

1. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature 2004;431:405-6. (Pubitemid 39329565)
2. Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008;8:618-31.
3. Pollard JW. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 2008;84:623-30.
4. Rehman J, Jingling L, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164-9.
5. Romagnani P, Annunziato F, Liotta F, Lazzeri E, Manzzinghi B, Frosali F, et al. CD14+CD34 low cells with stem cell phenotype and functional features are the major source of circulating endothelial progenitors. Circ Res 2005;97:314-22. (Pubitemid 41216135)
6. Sharpe EE, Teleron AA, Li B, Price J, Sands MS, Alford K, et al. The origin and in vivo significance of murine and human culture expanded endothelial progenitor cells (CE-EPCs). Am J Pathol 2006;168:1710-20.
7. Ingram DA, Mead LE, Tanaka H, Meade V, Fonoglio A, Mortell K, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004;104:2752-60. (Pubitemid 39434958)
8. Moldovan NI, Goldschmidt-Clermont PJ, Parker-Thornburg J, Shapiro SD, Kolattukudy PE. Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res 2000;87:341-3.
9. Kerjaschki D, Hurttary N, Raab I, Regele H, Bojarski-Nagy K, Bartel G, et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006;12:230-4. (Pubitemid 43214751)
10. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005;115:2363-72. (Pubitemid 41266198)
11. Bailey AS, Willenbring H, Jiang S, Anderson DA, Schroeder DA, Wong MH, et al. Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci U S A 2006;103:13156-61. (Pubitemid 44338932)
12. Krenning G, Dankers PYW, Jovanovic D, van Luyn MJA, Harmsen MC. Efficient differentiation of CD14+monocytic cells into endothelial cells on degradable biomaterials. Biomaterials 2007;28:1470-9. (Pubitemid 46039834)
13. Conejo-Garcia JR, Buckanovich RJ, Benencia F, Courreges M, Rubin SC, Carroll RG, et al. Vascular leukocytes contribute to tumor vascularization. Blood 2005;105:679-81. (Pubitemid 40070752)
14. Yang L, DeBusk LM, Fukuda K, Fingleton B, Green-Jarvis B, Shyr Y, et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor bearing host directly promotes tumor angiogenesis. Cancer Cell 2004;6:409-21. (Pubitemid 39361441)
15. Conejo-Garcia JR, Benencia F, Courreges M, Kang E, Mohamed-Hadley A, Buckanovich RJ, et al. Tumor-infiltrating dendritic cell precursors recruited by a b-defensin contribute to vasculogenesis under the influence of VEGF-A. Nature Med 2004;10:950-8. (Pubitemid 39273736)
16. Li B, Vincent A, Cates JM, Brantley DM, Polk DB, Young PP. Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res 2009;69:338-48.
17. Madlambayan GJ, Butler JM, Hosaka K, Jorgensen M, Fu D, Guthrie SM, et al. Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger. Blood 2009;114:4310-9.
18. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-9. (Pubitemid 46348173)
19. Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell 1994;77:477-8. (Pubitemid 24153987)
20. Meredith JE Jr., Schwartz MA. Integrins, adhesion and apoptosis. Trends Cell Biol 1997;7:146-50. (Pubitemid 27135573)
21. kim S, Bell K, Mousa SA, Varner JA. Regulation of angiogenesis in vivo by ligation of integrin a5b1 with the central cell-binding domain of fibronectin. Am J Pathol 2000;156:1345-61.
22. Koivunen E, Wang B, Ruoslahti E. Isolation of a highly specific ligand for the a5b1 integrin from a phage display library. J Cell Biol 1994;124:373-80. (Pubitemid 24050355)
23. Wijelath ES, Rahman S, Murray J, Patel Y, Savidge G, Sobel M. Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J Vasc Surg 2004;39:655-60. (Pubitemid 38298639)
24. Urbich C, Dimmeler S. Endothelial progenitor cells characterization and role in vascular biology. Circ Res 2004;95:343-53. (Pubitemid 39100452)
25. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-87. (Pubitemid 35283958)
26. Jin H, Su J, Garmy-Susini B, Kleeman J, Varner JA. Integrin a4b1 promotes monocyte trafficking and angiogenesis in tumor. Cancer Res 2006;66:2146-56.
27. Kim SB, Harris M, Varner JA. Regulation of integrin avb3-mediated endothelial cell migration and angiogenesis by integrin a5b1 and protein kinase A. J Biol Chem 2000;275:33920-8.
28. Balkwill F. Tumor necrosis factor and cancer. Nature Rev 2009;9:361-70.
29. Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C, et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 2005;111:1184-91. (Pubitemid 40365481)
30. Chakraborty S, Kang B, Huang F, Guo Y. Mouse embryonic stem cells lacking p38a and p38d can differentiate into endothelial cells, smooth muscle cells and epithelial cells. Differentiation 2009;78: 143-50.
31. Lu J, Zhao J, Liu K, Zhao J, Yang H, Huang Y, et al. MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma. Cell Mol Life Sci 2010;67:2091-106.
32. Hu Z, Tang M, Fisher AB, Olashaw N, Zuckerman KS. TNF-{alpha}- induced growth suppression of CD34 +myeloid leukemic cell lines through TNF receptor type I is associated with NF-kappa B activation. J Immunol 1999;163:3106-15. (Pubitemid 29431808)
33. Ido M, Hayashi K, Kato S, Ogawa H, Komada Y, Zhau YW, et al. Isolation and characterization of Kasumi-1 human myeloid leukaemia cell line resistant to tumour necrosis factor a-induced apoptosis. Br J Cancer 1996;73:360-5. (Pubitemid 26047515)
34. Li B, Sharpe EE, Teleron AA, Pyle AL, Carmeliet P, Young PP. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at site of tumor neovascularization. FASEB J 2006;20:1495-7.
35. De Palma M, Mazzieri R, Politi LS, Pucci F, Zonari E, Sitia G, et al. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell 2008;14:299-311.
36. Danen EJ, Sonneveld P, Brakebusch C, Fassler R, Sonnenberg A. The fibronectin-binding integrins a5b1 and avb3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis. J Cell Biol 2002;159:1071-86. (Pubitemid 36055761)
37. Eliceiri BP, Cheresh DA. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 1999;103:1227-30. (Pubitemid 29218291)
38. Zhang HT, Gorn M, Smith K, Graham AP, Lau KK, Bicknell R. Transcriptional profiling of human microvascular endothelial cells in the proliferative and quiescent state using cDNA arrays. Angiogenesis 1999;3:211-9. (Pubitemid 129644150)
39. Jin H, Varner J. Integrins: roles in cancer development and as treatment targets. Br J Cancer 2004;90:561-5. (Pubitemid 38297190)